Erlotinib vs Insulin Glargine

Erlotinib vs Insulin Glargine: Overview

This comparison examines the pharmacological differences between Erlotinib and Insulin Glargine.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Insulin Glargine: Long-acting insulin analogue that binds insulin receptors.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Insulin Glargine — 12-24 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4.

Molecular Weight: Erlotinib — 393.4380 g/mol.

Type: Erlotinib — Small molecule; Insulin Glargine — Protein.